Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy.
about
The androgen receptor gene mutations databaseAndrogen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicinePhenotypic variation and detection of carrier status in the partial androgen insensitivity syndromeAndrogen insensitivity.Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation.Identification of two transcription activation units in the N-terminal domain of the human androgen receptor.Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistanceTrinucleotide repeat polymorphism in the androgen receptor gene (AR).Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome.Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes.Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrationsMutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene.Differential splicing of human androgen receptor pre-mRNA in X-linked Reifenstein syndrome, because of a deletion involving a putative branch siteMolecular basis of androgen resistance.Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat.Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor.One additional mutation at exon A amplifies thermolability of androgen receptor in a case with complete androgen insensitivity syndrome.Androgen receptor-related diseases: what do we know?Genetic disorders of nuclear receptors.Mutations flanking the polyglutamine repeat in the modulatory domain of rat glucocorticoid receptor lead to an increase in affinity for hormone.Polymorphisms of the glucocorticoid receptor gene in laboratory and wild rats: steroid binding properties of trinucleotide CAG repeat length variants.Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation.Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne.Shortage of glutamine (CAG) homopolymeric repeats suppresses the expression of the androgen receptor in familial cases with complete androgen insensitivity syndrome.
P2860
Q24606948-6FFFB6B5-E26A-40B5-83AD-C46E81694897Q33518450-2591CFBD-BAF7-4E02-92A7-874529FDDA03Q33623221-F1A53A2E-29EE-4407-8C3C-CEE7C755C41FQ33869547-BB3D4FCF-A1B1-4617-9235-893DB525165EQ33893810-F11C53B9-BBEF-4226-9F0B-7BB2D2BF261EQ34058626-063E402B-9A3D-4FAA-BC54-C4C27A4C4089Q34190881-9CABDD2E-F063-48AF-9444-A27251846A9DQ34228679-CA25B7A5-7740-479C-8B30-C5A00E342A9EQ35064774-771B69A2-64ED-43A0-B5D0-3AC809F89B78Q35195367-31263424-30DD-4AA8-9A0A-AA830738E711Q35196168-3792092A-F6AB-4311-A9D4-723823F8A322Q35603379-76051F6D-4B8A-4C57-B01C-9A015FCF8524Q35609419-4636E2D3-A07E-4268-AE94-30B11E60FE64Q35888948-A4940BD4-B8AD-46CB-A9BF-159FEA56DED0Q36030970-9656FBDE-F099-4E6F-BACA-21DE6BE693A1Q37323212-8A001EC1-75C4-4FFC-9853-0AC660848634Q37332443-80D4E47B-8E9A-4095-A041-ACDB77376019Q38337050-CF3A085C-AE7E-43E2-B711-48B3B737AB66Q38780007-1A3DA13B-F5C6-4A87-9C0E-6DBCD2BF37DDQ39214888-201FF848-3EE7-4981-90D5-205916C65759Q40682633-59B0400C-9C92-47BD-9105-59ECDD6EFC24Q41058628-533DC542-8325-4526-AD4F-A9FD8F4088B9Q44360255-8D63D6DD-A060-4C79-BC94-D2A8B2F90883Q47793235-3597C6E0-6B07-4024-8000-3D48C0105173Q52189336-7BA926B2-4F0C-4DF2-8F14-EB47A69976A6
P2860
Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy.
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Molecular basis of androgen re ...... to high-dose androgen therapy.
@ast
Molecular basis of androgen re ...... to high-dose androgen therapy.
@en
Molecular basis of androgen re ...... to high-dose androgen therapy.
@nl
type
label
Molecular basis of androgen re ...... to high-dose androgen therapy.
@ast
Molecular basis of androgen re ...... to high-dose androgen therapy.
@en
Molecular basis of androgen re ...... to high-dose androgen therapy.
@nl
prefLabel
Molecular basis of androgen re ...... to high-dose androgen therapy.
@ast
Molecular basis of androgen re ...... to high-dose androgen therapy.
@en
Molecular basis of androgen re ...... to high-dose androgen therapy.
@nl
P2093
P2860
P356
P1476
Molecular basis of androgen re ...... to high-dose androgen therapy.
@en
P2093
J D Wilson
J E Griffin
M J McPhaul
M Marcelli
R F Isidro-Gutierrez
W D Tilley
P2860
P304
P356
10.1172/JCI115147
P407
P577
1991-04-01T00:00:00Z